Back to Search
Start Over
Phase II clinical trial with long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 (IL2) in patients with high risk neuroblastoma
- Source :
- Journal of Clinical Oncology. 34:10562-10562
- Publication Year :
- 2016
- Publisher :
- American Society of Clinical Oncology (ASCO), 2016.
-
Abstract
- 10562Background: A new delivery method of anti-GD2 antibody ch14.18/CHO by long term infusion (LTI) may improve the toxicity profile but maintain effective immune modulation and clinical activity i...
- Subjects :
- Interleukin 2
Cancer Research
biology
business.industry
Anti-GD2 Antibody
Pharmacology
Immune modulation
030226 pharmacology & pharmacy
Clinical trial
03 medical and health sciences
0302 clinical medicine
Oncology
biology.protein
Medicine
In patient
High risk neuroblastoma
Antibody
business
Toxicity profile
030217 neurology & neurosurgery
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........a3d38a1a61f56f4714f8c61ab7a34c05
- Full Text :
- https://doi.org/10.1200/jco.2016.34.15_suppl.10562